SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-009146
Filing Date
2024-02-01
Accepted
2024-02-01 08:00:41
Documents
14
Period of Report
2024-02-01
Items
Item 1.03: Bankruptcy or Receivership

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244807d1_8k.htm   iXBRL 8-K 23527
  Complete submission text file 0001104659-24-009146.txt   195097

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nviv-20240201.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nviv-20240201_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nviv-20240201_pre.xml EX-101.PRE 22379
15 EXTRACTED XBRL INSTANCE DOCUMENT tm244807d1_8k_htm.xml XML 3513
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 24585092
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)